Zubeyde Ercan1, Gulnihal Deniz2, Songül Baglan Yentur3, Funda Bulut Arikan4, Ahmet Karatas5, Gokhan Alkan6, Suleyman Serdar Koca5. 1. Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Firat University, Elazig, Turkey. zubeydeercan@firat.edu.tr. 2. Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Erzurum Technical University, Erzurum, Turkey. 3. Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Firat University, Elazig, Turkey. 4. Department of Physiology, Faculty of Medicine, Kirikkale University, Kirikkale, Turkey. 5. Department of Rheumatology, Faculty of Medicine, Firat University, Elazig, Turkey. 6. Department of Physical Therapy and Rehabilitation, Faculty of Medicine, Firat University, Elazig, Turkey.
Abstract
BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that causes cartilage and bone damage as well as disability. AIMS : The aim of this study was to examine the effects of acute aerobic exercise on cytokines such as serum interleukin-6 (IL-6), interleukin-1β (IL-1β), Tumor Necrosis Factor-α (TNF-α) and irisin, vascular endothelial growth factor(VEGF) and klotho in RA patients. METHODS: Forty RA patient and 40 healthy volunteers of the same age participated in this study. All participants walked on the treadmill for 30 minutes at 60-80% of maximal heart rate. Blood samples were taken before and immediately after the exercise. Serum levels of IL-6, IL1β, TNF-α and irisin, VEGF and klotho were measured by enzyme-linked immunosorbent analysis. RESULTS: Baseline levels of inflammatory cytokines, irisin, VEGF and klotho were found to be higher in RA patients compared to the control group. In both groups, there was an increase in serum klotho levels after exercise compared to baseline (p<0.05), while a decrease in IL1β, TNF-α levels were observed. While serum VEGF level decreased in RA group, it increased in the control group(p<0.05). Irisin levels decreased in both groups. IL-6 level did not change in the control group, while it increased in RA group. A single exercise session had an acute anti-inflammatory effect in RA patients. CONCLUSION: It can be concluded that acute aerobic exercise can be beneficial for patients with RA through cytokine, irisin, klotho and VEGF levels, and also it can be safely implemented to the RA rehabilitation program for additional anti-inflammatory effects. Trial registration ClinicalTrials.gov: NCT04439682.
BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that causes cartilage and bone damage as well as disability. AIMS : The aim of this study was to examine the effects of acute aerobic exercise on cytokines such as serum interleukin-6 (IL-6), interleukin-1β (IL-1β), Tumor Necrosis Factor-α (TNF-α) and irisin, vascular endothelial growth factor(VEGF) and klotho in RA patients. METHODS: Forty RA patient and 40 healthy volunteers of the same age participated in this study. All participants walked on the treadmill for 30 minutes at 60-80% of maximal heart rate. Blood samples were taken before and immediately after the exercise. Serum levels of IL-6, IL1β, TNF-α and irisin, VEGF and klotho were measured by enzyme-linked immunosorbent analysis. RESULTS: Baseline levels of inflammatory cytokines, irisin, VEGF and klotho were found to be higher in RA patients compared to the control group. In both groups, there was an increase in serum klotho levels after exercise compared to baseline (p<0.05), while a decrease in IL1β, TNF-α levels were observed. While serum VEGF level decreased in RA group, it increased in the control group(p<0.05). Irisin levels decreased in both groups. IL-6 level did not change in the control group, while it increased in RA group. A single exercise session had an acute anti-inflammatory effect in RA patients. CONCLUSION: It can be concluded that acute aerobic exercise can be beneficial for patients with RA through cytokine, irisin, klotho and VEGF levels, and also it can be safely implemented to the RA rehabilitation program for additional anti-inflammatory effects. Trial registration ClinicalTrials.gov: NCT04439682.
Authors: H Sone; M Sakauchi; A Takahashi; H Suzuki; N Inoue; K Iida; H Shimano; H Toyoshima; Y Kawakami; Y Okuda; K Matsuo; N Yamada Journal: Life Sci Date: 2001-09-07 Impact factor: 5.037
Authors: M Harada; K Mitsuyama; H Yoshida; S Sakisaka; E Taniguchi; T Kawaguchi; M Ariyoshi; T Saiki; M Sakamoto; K Nagata; M Sata; K Matsuo; K Tanikawa Journal: Scand J Rheumatol Date: 1998 Impact factor: 3.641
Authors: Kristin I Stanford; Roeland J W Middelbeek; Kristy L Townsend; Min-Young Lee; Hirokazu Takahashi; Kawai So; Kristen M Hitchcox; Kathleen R Markan; Katharina Hellbach; Michael F Hirshman; Yu-Hua Tseng; Laurie J Goodyear Journal: Diabetes Date: 2015-01-20 Impact factor: 9.461
Authors: Hirokazu Takahashi; Christiano R R Alves; Kristin I Stanford; Roeland J W Middelbeek; Pasquale Nigro; Rebecca E Ryan; Ruidan Xue; Masaji Sakaguchi; Matthew D Lynes; Kawai So; Joram D Mul; Min-Young Lee; Estelle Balan; Hui Pan; Jonathan M Dreyfuss; Michael F Hirshman; Mohamad Azhar; Jarna C Hannukainen; Pirjo Nuutila; Kari K Kalliokoski; Søren Nielsen; Bente K Pedersen; C Ronald Kahn; Yu-Hua Tseng; Laurie J Goodyear Journal: Nat Metab Date: 2019-02-11